Table 2 Inclusion and exclusion criteria

Clinical

Oncologists, surgeons, radiologists, other HCC and hepatobiliary specialists, hepatologists, pathologists, and other specialists who may be involved in HCC prevention, diagnosis, treatment and care, or leaders of major medical institutions (including cancer and other liver disease centers).

Not board certified, certified for less than one year, practicing medicine for less than 3 years, living/practicing in country for less than 3 years.

Policy

Individuals in government, NGOs or other agencies involved in public education, awareness and prevention related to liver disease and liver cancer; national formularies and reimbursement decision-making; the development of policy and/or guidelines for the control of liver cancer; or those involved in policy related to liver transplantation.

Less than 1 year’s experience in liver cancer and related fields; those not directly involved in policies impacting liver cancer prevention and control; or those with primary responsibilities as (and who otherwise primarily identify themselves as liver cancer) clinicians, advocates or in non-policy related roles.

Advocacy

Recognized by liver cancer patients, physicians or policy leaders for their national advocacy role; significant consumer/patient advocacy of liver disease; leadership role in a nationally recognized advocacy group; evidence of an active media and/or publication history that is targeted to reach liver cancer patient or at-risk consumer populations.

Those with primary responsibilities as clinicians or in non-advocacy related roles; those whose scope of advocacy is limited to local environs, i.e. with little/no national impact or recognition by peers, clinical and policy leaders.